Fr Muller Homoeopathic Medical College Hospital
Mangalore, Karnataka, 575018, India
NCT Number: NCT01527760
To estimate the effectiveness of Viscum album Homoeopathic mother tincture in Essential Hypertension by conducting clinical trial in moderate hypertensive patients for a period of six weeks.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Mangalore, Karnataka, 575018, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ten drops of Drug in 30 ml of distilled water with a frequency of three times a day for a duration of 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks
Time frame: 12 weeks and 16 weeks
The blood sample was collected at the end of 12 weeks of medication followed by a drug free period of 4 weeks.The blood sample was collected again at the end of 4 weeks of drug free period to ascertain serum CKMB.
Fr Muller Homoeopathic Medical College
Other
Effectiveness of Viscum Album Mother Tincture as an Anti-hypertensive in Essential Hypertension. One Group Pretest Posttest Design
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06682000
Cardiovascular Diseases, Essential Hypertension
Seoul, South Korea
View Trial DetailsNCT07564726
Cardiovascular Diseases, Dyslipidemias
Ansan, South Korea
View Trial DetailsNCT07433790
Cardiovascular Diseases, Essential Hypertension
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT03503773
Cardiovascular Diseases, Essential Hypertension
Brussels, Belgium
View Trial Details